Brett Mitchell, BEc Executive Chairman
Qualications and Experience Mr Mitchell is a corporate nance executive with over 25 years of experience in
the venture capital, capital markets, tech and resources industries.
He has been involved in the founding, nancing and management of both
private and publicly-listed companies, including the second listed medical
cannabis company on the ASX – MGC Pharmaceuticals Ltd (MXC).
Brett is also founder and director of Chieftain Securities Pty Ltd, a Perth
based Corporate Advisory & Venture Capital rm and founder and
shareholder of Graft Polymer (UK) Ltd.
Interest in Shares and Options Brett and Michelle Mitchell <Mitchell Spring Family A/C>
20,458,889 Ordinary Shares
Brett and Michelle Mitchell <Lefthanders Super Fund A/C>
5,735,005 Ordinary Shares
Directorships held in other listed entities
in the past three years
Sky and Space Global Ltd (12 May 2016 – current)
TNT Mines Limited (27 June 2017 – current)
Acacia Coal Limited (18 December 2015 – 2 August 2016)
Digital CC Limited (5 September 2014 – 24 July 2016)
Roby Zomer Managing Director
Qualications and Experience Mr Zomer joined Mr Segev as co-founder of MGC Pharma and then as the
Executive Director & CTO, following 10 years of experience in the BioTech
and AgroTech sectors, alongside running large scale projects. Mr Zomer
brings his extensive list of business contacts and scientic and engineering
expertise to ensure MXC is positioned as a leader in research and development,
in addition to guaranteeing top performance from global operations.
Mr Zomer’s recent appointment to Managing Director follows successful
implementation of MXC’s pipelines for pharmaceuticals in Europe and
Australia, and indicates MXC’s commitment to scientic leadership.
Interest in Shares and Options Chitta Lu Limited
10,000,000 Performance Shares
HSBC Custody Nominees (Australia) Limited
30,000,000 Ordinary Shares
Directorships held in other listed entities
in the past three years
Nil
Nativ Segev Executive Director and Head of Business Strategy
Qualications and Experience Mr Segev founded MGC Pharma in 2014 with a goal to expand into
international markets and raise the quality of medicinal Phytocannabinoid
products, in addition to making them accessible to patients all over the
world. Prior to establishing MGC Pharma, Mr. Segev was a leader in the
Medical Cannabis industry with a sizeable patient-base.
He has over 10 years of experience in implementation, legislation and
lobbying in the global Medical Cannabis industry, combined with over 15
years of experience in diverse executive roles.
Interest in Shares and Options 20,000,000 Performance Shares
HSBC Custody Nominees (Australia) Limited
52,500,000 Ordinary Shares
Directorships held in other listed entities
in the past three years
Nil
Ross Walker, MBBS (Hons), FRACP, FCSANZ Non-Executive Director and Chairman of Strategic Advisory Board
Qualications and Experience Dr Ross Walker is an eminent practicing cardiologist with over 35 years’
experience as a clinician. For the past 20 years, he has been focusing on
preventative cardiology and is one of Australia’s leading preventative
health experts.
Dr Walker is considered one of the world’s best keynote speakers and life
coaches, he is the author of seven best-selling books, a health presenter in
the Australian Media, including regular appearances on the Nine Network’s
‘Today Show’ and ‘A Current Affair’, and Sky News, Switzer Business.
Interest in Shares and Options 4,000,000 Ordinary Shares
Directorships held in other listed entities
in the past three years
Nil
Rachel Kerr Joint Company Secretary
Qualications and Experience Mrs Kerr has 9 years’ experience as a Company Secretary on
both private and public companies, working on acquisitions,
capital raisings, listing of companies on ASX, due diligence
reviews and compliance of public companies. Mrs Kerr is
also Joint Company Secretary of Sky and Space Global.
Kate Sainty Joint Company Secretary
Qualications and Experience Mrs Sainty is a Chartered Accountant and Chartered Secretary. Mrs
Sainty was appointed to the position of Joint Company Secretary on 1
January 2018 and is an employee of Grange Consulting Group providing
a unique range of corporate and nancial services to listed and unlisted
companies. Mrs Sainty is also Joint Company Secretary of Syntonic Limited.
Directors Report
mgcpharma.com.au
18